{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T21:17:54Z","timestamp":1762377474007,"version":"build-2065373602"},"reference-count":42,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Children"],"abstract":"<jats:p>Cannabinoids are prescribed to children with cerebral palsy despite limited evidence. We aimed to assess cannabinoid prescribing practices in children with cerebral palsy, focusing on indications, types of preparations used, and tolerability. Furthermore, we investigated how physicians acquire knowledge about cannabinoid medication. We asked physicians with expertise in the care of children with cerebral palsy about their prescribing practices for cannabinoids. Data were collected through an online survey, which was distributed by email. In addition to the demographic information of participants, we also inquired about the indications for the prescription of cannabinoids, experiences regarding efficacy, and observed side effects of the therapy. Seventy physicians from Europe, North America, and Australia completed the survey. Forty-seven participants were experienced in treating of children with cerebral palsy with cannabinoids. The most common indication was epilepsy (69%), followed by spasticity (64%) and pain (63%). The preparations and doses prescribed varied considerably. Half of the participants evaluated the effect of the cannabinoids as moderate. Twenty-nine physicians reported side effects, most frequently, drowsiness (26%), somnolence (19%), fatigue (13%), and diarrhea (13%). Despite the lack of evidence to date, cannabinoids are used to treat children with cerebral palsy in a wide variety of indications. Randomized controlled trials in this vulnerable patient group are therefore of utmost importance.<\/jats:p>","DOI":"10.3390\/children10121838","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T06:06:23Z","timestamp":1700719583000},"page":"1838","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prescription Practices of Cannabinoids in Children with Cerebral Palsy Worldwide\u2014A Survey of the Swiss Cerebral Palsy Registry"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3914-4987","authenticated-orcid":false,"given":"Sandra","family":"Hunziker","sequence":"first","affiliation":[{"name":"Institute of Social and Preventive Medicine, University of Bern, Mittelstrasse 43, CH-3012 Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Morosoli","sequence":"additional","affiliation":[{"name":"Division of Neuropediatrics, Development and Rehabilitation, Children\u2019s University Hospital, Inselspital, University of Bern, Freiburgstr. 15, CH-3010 Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrin","family":"Zuercher","sequence":"additional","affiliation":[{"name":"Institute of Social and Preventive Medicine, University of Bern, Mittelstrasse 43, CH-3012 Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Tscherter","sequence":"additional","affiliation":[{"name":"Institute of Social and Preventive Medicine, University of Bern, Mittelstrasse 43, CH-3012 Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2820-9650","authenticated-orcid":false,"given":"Sebastian","family":"Grunt","sequence":"additional","affiliation":[{"name":"Division of Neuropediatrics, Development and Rehabilitation, Children\u2019s University Hospital, Inselspital, University of Bern, Freiburgstr. 15, CH-3010 Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,23]]},"reference":[{"key":"ref_1","first-page":"8","article-title":"A report: The definition and classification of cerebral palsy april 2006","volume":"109","author":"Rosenbaum","year":"2007","journal-title":"Dev. Med. Child Neurol. Suppl."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Surveillance of Cerebral Palsy in Europe (2000). Surveillance of cerebral palsy in europe: A collaboration of cerebral palsy surveys and registers. Surveillance of cerebral palsy in europe (scpe). Dev. Med. Child. Neurol., 42, 816\u2013824.","DOI":"10.1111\/j.1469-8749.2000.tb00695.x"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"103500","DOI":"10.1016\/j.ridd.2019.103500","article-title":"Behavioral difficulties, sleep problems, and nighttime pain in children with cerebral palsy","volume":"95","author":"Horwood","year":"2019","journal-title":"Res. Dev. Disabil."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.sleh.2019.08.006","article-title":"A systematic review and meta-analysis of the prevalence of sleep problems in children with cerebral palsy: How do children with cerebral palsy differ from each other and from typically developing children?","volume":"5","author":"Horwood","year":"2019","journal-title":"Sleep Health"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S1059131102002558","article-title":"Epilepsy in children with cerebral palsy","volume":"12","author":"Gururaj","year":"2003","journal-title":"Seizure"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/dmcn.14188","article-title":"Long-term prognosis of epilepsy in patients with cerebral palsy","volume":"61","author":"Tsubouchi","year":"2019","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/08830738030180030601","article-title":"Epilepsy in children with cerebral palsy","volume":"18","author":"Singhi","year":"2003","journal-title":"J. Child Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.rehab.2020.01.005","article-title":"Cognitive and academic profiles in children with cerebral palsy: A narrative review","volume":"63","author":"Fluss","year":"2020","journal-title":"Ann. Phys. Rehabil. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/dmcn.12246","article-title":"A systematic review of interventions for children with cerebral palsy: State of the evidence","volume":"55","author":"Novak","year":"2013","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_10","first-page":"CD012430","article-title":"Trihexyphenidyl for dystonia in cerebral palsy","volume":"5","author":"Harvey","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_11","first-page":"CD004552","article-title":"Intrathecal baclofen for treating spasticity in children with cerebral palsy","volume":"2015","author":"Hasnat","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_12","first-page":"CD003469","article-title":"Botulinum toxin a as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (update)","volume":"2010","author":"Hoare","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/157488611798280924","article-title":"Safety and side effects of cannabidiol, a cannabis sativa constituent","volume":"6","author":"Bergamaschi","year":"2011","journal-title":"Curr. Drug Saf."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e20171818","DOI":"10.1542\/peds.2017-1818","article-title":"Medical cannabinoids in children and adolescents: A systematic review","volume":"140","author":"Wong","year":"2017","journal-title":"Pediatrics"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","article-title":"Trial of cannabidiol for drug-resistant seizures in the dravet syndrome","volume":"376","author":"Devinsky","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","article-title":"Effect of cannabidiol on drop seizures in the lennox-gastaut syndrome","volume":"378","author":"Devinsky","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","article-title":"Cannabidiol in patients with seizures associated with lennox-gastaut syndrome (gwpcare4): A randomised, double-blind, placebo-controlled phase 3 trial","volume":"391","author":"Thiele","year":"2018","journal-title":"Lancet"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e0003","DOI":"10.5041\/RMMJ.10386","article-title":"Medical cannabis in children","volume":"11","author":"Aran","year":"2020","journal-title":"Rambam Maimonides Med. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/dmcn.14087","article-title":"Efficacy of cannabinoids in paediatric epilepsy","volume":"61","author":"Ali","year":"2019","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1055\/a-2002-2119","article-title":"Clinical outcome data of children treated with cannabis-based medicinal products for treatment resistant epilepsy-analysis from the uk medical cannabis registry","volume":"54","author":"Erridge","year":"2023","journal-title":"Neuropediatrics"},{"key":"ref_21","first-page":"w14463","article-title":"Medical use of cannabis in switzerland: Analysis of approved exceptional licences","volume":"147","author":"Kilcher","year":"2017","journal-title":"Swiss Med. Wkly."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for medical use: A systematic review and meta-analysis","volume":"313","author":"Whiting","year":"2015","journal-title":"JAMA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11910-018-0814-x","article-title":"The use of cannabis and cannabinoids in treating symptoms of multiple sclerosis: A systematic review of reviews","volume":"18","author":"Nielsen","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ctim.2017.08.010","article-title":"Cannabinoids for spasticity due to multiple sclerosis or paraplegia: A systematic review and meta-analysis of randomized clinical trials","volume":"34","author":"Magalhaes","year":"2017","journal-title":"Complement. Ther. Med."},{"key":"ref_25","first-page":"CD007786","article-title":"Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood","volume":"2","author":"Phillips","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.ejpn.2016.07.021","article-title":"Effective treatment of spasticity using dronabinol in pediatric palliative care","volume":"20","author":"Kuhlen","year":"2016","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/dmcn.14874","article-title":"Pharmacological and neurosurgical interventions for individuals with cerebral palsy and dystonia: A systematic review update and meta-analysis","volume":"63","author":"Bohn","year":"2021","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/dmcn.14165","article-title":"Cannabinoids for the treatment of spasticity","volume":"61","author":"Nielsen","year":"2019","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/dmcn.14548","article-title":"Efficacy and safety of nabiximols cannabinoid medicine for paediatric spasticity in cerebral palsy or traumatic brain injury: A randomized controlled trial","volume":"62","author":"Fairhurst","year":"2020","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/pch\/pxaa031","article-title":"Efficacy and safety of paediatric medicinal cannabis use: A scoping review","volume":"26","author":"Pawliuk","year":"2021","journal-title":"Paediatr. Child Health"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"E206","DOI":"10.1503\/cmaj.191097","article-title":"Drug interactions with cannabinoids","volume":"192","author":"Antoniou","year":"2020","journal-title":"Can. Med. Assoc. J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00431-021-04202-z","article-title":"Use and caregiver-reported efficacy of medical cannabis in children and adolescents in switzerland","volume":"181","author":"Zurcher","year":"2022","journal-title":"Eur. J. Pediatr."},{"key":"ref_33","first-page":"1","article-title":"Exploring the effectiveness of chain referral methods in sampling hidden populations","volume":"8","author":"Bagheri","year":"2015","journal-title":"Indian J. Sci. Technol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/dmcn.14606","article-title":"Efficacy of cannabinoids for treating paediatric spasticity in cerebral palsy or traumatic brain injury: What is the evidence?","volume":"62","author":"Nielsen","year":"2020","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1097\/j.pain.0000000000001293","article-title":"Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: A systematic review and meta-analysis of controlled and observational studies","volume":"159","author":"Stockings","year":"2018","journal-title":"Pain"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"E755","DOI":"10.36076\/ppj.20.5.E755","article-title":"Efficacy of cannabis-based medicines for pain management: A systematic review and meta-analysis of randomized controlled trials","volume":"20","author":"Aviram","year":"2017","journal-title":"Pain Physician"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/dmcn.14111","article-title":"Prevalence and characteristics of pain in children and young adults with cerebral palsy: A systematic review","volume":"61","author":"McKinnon","year":"2019","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s10072-019-04196-5","article-title":"Cannabinoids and dystonia: An issue yet to be defined","volume":"41","author":"Mascia","year":"2020","journal-title":"Neurol. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0883073818773028","article-title":"Medical cannabis for pediatric moderate to severe complex motor disorders","volume":"33","author":"Libzon","year":"2018","journal-title":"J. Child Neurol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"156","DOI":"10.7812\/TPP\/20.156","article-title":"The role of cannabidiol in neurological disorders","volume":"25","author":"Chayasirisobhon","year":"2021","journal-title":"Perm. J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.tips.2009.07.006","article-title":"Non-psychotropic plant cannabinoids: New therapeutic opportunities from an ancient herb","volume":"30","author":"Izzo","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-3-030-21737-2_8","article-title":"Pharmacology of medical cannabis","volume":"1162","author":"Amin","year":"2019","journal-title":"Adv. Exp. Med. Biol."}],"container-title":["Children"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9067\/10\/12\/1838\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:28:13Z","timestamp":1760131693000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9067\/10\/12\/1838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,23]]},"references-count":42,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["children10121838"],"URL":"https:\/\/doi.org\/10.3390\/children10121838","relation":{},"ISSN":["2227-9067"],"issn-type":[{"type":"electronic","value":"2227-9067"}],"subject":[],"published":{"date-parts":[[2023,11,23]]}}}